1. |
Li H, Xie L, Yang J, et al. Symptom burden amongst patients suffering from end-stage renal disease and receiving dialysis: a literature review[J]. Int J Nurs Sci, 2018, 5(4): 427-431. DOI: 10.1016/j.ijnss.2018.09.010.
|
2. |
Jha V, Garcia-Garcia G, Iseki K, et al. Chronic kidney disease: global dimension and perspectives[J]. Lancet, 2013, 382(9888): 260-272. DOI: 10.1016/S0140-6736(13)60687-X.
|
3. |
Krediet RT, Abrahams AC, de Fijter CWH, et al. The truth on current peritoneal dialysis: state of the art[J]. Neth J Med, 2017, 75(5): 179-189.
|
4. |
Mehrotra R, Devuyst O, Davies SJ, et al. The current state of peritoneal dialysis[J]. J Am Soc Nephrol, 2016, 27(11): 3238-3252. DOI: 10.1681/ASN.2016010112.
|
5. |
Shi J, Yu M, Sheng M. Angiogenesis and inflammation in peritoneal dialysis: the role of adipocytes[J]. Kidney Blood Press Res, 2017, 42(2): 209-219. DOI: 10.1159/000476017.
|
6. |
Fabbrini P, Schilte MN, Zareie M, et al. Celecoxib treatment reduces peritoneal fibrosis and angiogenesis and prevents ultrafiltration failure in experimental peritoneal dialysis[J]. Nephrol Dial Transplant, 2009, 24(12): 3669-3676. DOI: 10.1093/ndt/gfp384.
|
7. |
Khadamy J, Abri Aghdam K, Falavarjani KG. An update on optical coherence tomography angiography in diabetic retinopathy[J]. Ophthalmic Vis Res, 2018, 13(4): 487-497. DOI: 10.4103/jovr.jovr_57_18.
|
8. |
Ulaş F, Doğan Ü, Keleş A, et al. Evaluation of choroidal and retinal thickness measurements using optical coherence tomography in non-diabetic haemodialysis patients[J]. Int Ophthalmol, 2013, 33(5): 533-539. DOI: 10.1007/s10792-013-9740-8.
|
9. |
Sun G, Hao R, Zhang L, et al. The effect of hemodialysis on ocular changes in patients with the end-stage renal disease[J]. Ren Fail, 2019, 41(1): 629-635. DOI: 10.1080/0886022X.2019.1635494.
|
10. |
Tan ACS, Tan GS, Denniston AK, et al. An overview of the clinical applications of optical coherence tomography angiography[J]. Eye (Lond), 2018, 32(2): 262-286. DOI: 10.1038/eye.2017.181.
|
11. |
Mogi M, Horiuchi M. Clinical interaction between brain and kidney in small vessel disease[J/OL]. Cardiol Res Pract, 2011, 2011: 306189[2011-01-09]. https://pubmed.ncbi.nlm.nih.gov/21274446/. DOI: 10.4061/2011/306189.
|
12. |
陈露璐, 陈有信. 光相干断层扫描血管成像在视网膜静脉阻塞中的应用研究进展[J]. 中华眼底病杂志, 2019, 35(4): 399-402. DOI: 10.3760/cma.j.issn.1005-1015.2019.04.021.Chen LL, Chen YX. Research progress of optical coherence tomography angiography in retinal vein occlusion[J]. Chin J Ocul Fundus Dis, 2019, 35(4): 399-402. DOI: 10.3760/cma.j.issn.1005-1015.2019.04.021.
|
13. |
肖世禹, 朱瑞琳, 杨柳. 光相干断层扫描血管成像在非感染性葡萄膜炎中的应用研究现状[J]. 中华眼底病杂志, 2019, 35(4): 403-408. DOI: 10.3760/cma.j.issn.1005-1015.2019.04.022.Xiao SY, Zhu RL, Yang L. The status in the application of optical coherence tomography angiography in noninfectious uveitis[J]. Chin J Ocul Fundus Dis, 2019, 35(4): 403-408. DOI: 10.3760/cma.j.issn.1005-1015.2019.04.022.
|
14. |
Iftikhar M,Zafar S,Gonzalez N, et al. Image artifacts in optical coherence tomography angiography among patients with multiple sclerosis[J]. Curr Eye Res, 2019, 44(5): 558-563. DOI: 10.1080/02713683.2019.1565892.
|
15. |
O'Bryhim BE, Apte RS, Kung N, et al. Association of preclinical alzheimer disease with optical coherence tomographic angiography findings[J]. JAMA Ophthalmol, 2018, 136(11): 1242-1248. DOI: 10.1001/jamaophthalmol.2018.3556.
|
16. |
Stenvinkel P, Carrero JJ, Axelsson J, et al. Emerging biomarkers for evaluating cardiovascular risk in the chronic kidney disease patient: how do new pieces fit into the uremic puzzle?[J]. Clin J Am Soc Nephrol, 2008, 3(2): 505-521. DOI: 10.2215/CJN.03670807.
|
17. |
Dai L, Golembiewska E, Lindholm B, et al. End-stage renal disease, inflammation and cardiovascular outcomes[J]. Contrib Nephrol, 2017, 191: 32-43. DOI: 10.1159/000479254.
|
18. |
Lee WH, Park JH, Won Y, et al. Retinal microvascular change in hypertension as measured by optical coherence tomography angiography[J/OL]. Sci Rep, 2019, 9(1): 156[2019-01-17]. https://pubmed.ncbi.nlm.nih.gov/30655557/. DOI: 10.1038/s41598-018-36474-1.
|
19. |
Pascual-Prieto J, Burgos-Blasco B, Ávila Sánchez-Torija M, et al. Utility of optical coherence tomography angiography in detecting vascular retinal damage caused by arterial hypertension[J]. Eur J Ophthalmol, 2020, 30(3): 579-585. DOI: 10.1177/1120672119831159.
|
20. |
Lim HB, Lee MW, Park JH, et al. Changes in ganglion cell–Inner plexiform layer thickness and retinal microvasculature in hypertension: an optical coherence tomography angiography study[J]. Am J Ophthalmol, 2019, 199: 167-176. DOI: 10.1016/j.ajo.2018.11.016.
|
21. |
Takayama K, Kaneko H, Ito Y, et al. Novel classification of early-stage systemic hypertensive changes in human retina based on OCTA measurement of choriocapillaris[J/OL]. Sci Rep, 2018, 8(1): 15163[2018-08-11]. https://pubmed.ncbi.nlm.nih.gov/30310137/. DOI: 10.1038/s41598-018-33580-y.
|
22. |
Keith NM, Wagener HP, Barker NW. Some different types of essential hypertension: their course and prognosis[J]. Am J Med Sci, 1974, 268(6): 336-345. DOI: 10.1097/00000441-197412000-00004.
|
23. |
Mullaem G, Rosner MH. Ocular problems in the patient with end-stage renal disease[J]. Semin Dial, 2012, 25(4): 403-407. DOI: 10.1111/j.1525-139X.2012.01098.x.
|
24. |
Vlahu CA, Aten J, de Graaff M, et al. New Insights into the effects of chronic kidney failure and dialysate exposure on the peritoneum[J]. Perit Dial Int, 2016, 36(6): 614-622. DOI: 10.3747/pdi.2015.00204.
|